Identified cancer stem cells and phenotypes
Tissue and/or Cancer | Phenotype and/or Surface Expression | Other Relevant Marker Expression | Identifying Reference |
---|---|---|---|
Leukemia (acute myelogenous leukemia) | CD34+/CD38−/CD90− | Lapidot et al. (16); Bonnet et al. (18) | |
Breast | CD44+/CD24−/low/Lin− | Lin−, ESA+,CD133+ | Al-Hajj et al. (19); Wright et al. (20) |
Squamous cell cancer of head and neck | CD44+/Lin− | BMI1+ (nuclear) | Prince et al. (21) |
Melanoma | ABCB5+ | Schatton et al. (22) | |
Colon | CD133+ | Haraguchi et al. (23); O'Brien et al. (24) | |
Liver hepatocellular cancer | CD133+ | ALDH+ | Ma et al. (25) |
Prostate | CD44+/α2β1hi/CD133+ | Collins et al. (26) | |
Glioblastoma | CD133+ | Singh et al. (27) | |
Pancreas | CD44+/CD24+/ESA+ | CD133+ | Li et al. (1); Hermann et al. (2) |
Ovarian | BCRP1+; CD44+/CD133+ | Verapamil_sensitive, CD44+, CD117+ (c-kit) | Szotek et al. (28); Zhang et al. (75) |